Balanced news tone
News Sentiment
KMDA sentiment intelligence
Kamada Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
53
Balanced news tone
18 relevant articles
News tone and price action are not far from neutral.
76/100 classification confidence.
directly relevant articles
high-authority source matches
+0.0% over one week, +0.6% over four weeks, trend inactive, and below fair value.
Kamada stock holds at Buy as Benchmark cites $50M plasma deal
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
76/100 classification
One-week reaction
0.0%
Price digesting
Trend fit
Trend inactive
0.6% over four weeks
Fair value
-99.0%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
4
Neutral
12
Negative
2
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Investing.com
Direct company coverage
Kamada stock holds at Buy as Benchmark cites $50M plasma deal
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 21 Jul 2026 14:58
- Source
- Investing.com
GuruFocus
Direct company coverage
Kamada (KMDA) Secures $50M Plasma Supply Agreement
- Tone
- Neutral 50/100
- Event
- Macro sensitivity
- Published
- 20 Jul 2026 12:43
- Source
- GuruFocus
Stock Titan
Direct company coverage
Kamada Ltd. (NASDAQ: KMDA) signs three-year $50M plasma supply agreement
- Tone
- Neutral 50/100
- Event
- Macro sensitivity
- Published
- 20 Jul 2026 11:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
Kamada’s centers plan ~50,000 liters of plasma each at full capacity
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Jul 2026 11:00
- Source
- Stock Titan
Investing.com UK
Direct company coverage
Kamada highlights study results on CYTOGAM in transplants
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 16:20
- Source
- Investing.com UK
Stock Titan
Direct company coverage
[6-K] KAMADA LTD Current Report (Foreign Issuer) | KMDA SEC Filing - Form 6-K
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 11:47
- Source
- Stock Titan
dars.gov.et
Direct company coverage
Kamada Ltd. (KMDA) Posts Modest Gain as Shares Hold Above Key Support Level - Overbought Signal Alerts
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- dars.gov.et
Seeking Alpha
Direct company coverage
Kamada: Undervalued, Yet Execution Risks Keep It A Hold (NASDAQ:KMDA)
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- Seeking Alpha
Stock Titan
Direct company coverage
Rabies antibody testing: FDA approves Kamada’s rare gold-standard lab
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- Stock Titan
dars.gov.et
Direct company coverage
Kamada Ltd. (KMDA) Holds Steady Near Support as Trading Volume Remains Moderate - Shakeout Pattern
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 May 2026 07:00
- Source
- dars.gov.et
GlobeNewswire
Direct company coverage
Kamada Reports First Quarter 2026 Financial Results and
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 May 2026 07:00
- Source
- GlobeNewswire
Stock Titan
Direct company coverage
Kamada will post quarterly results before markets open on May 13
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 06 May 2026 07:00
- Source
- Stock Titan
GlobeNewswire
Direct company coverage
Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 31 Mar 2026 07:00
- Source
- GlobeNewswire
Seeking Alpha
Direct company coverage
Kamada: From Buy To Hold After 22.4% Surge (Rating Downgrade) (NASDAQ:KMDA)
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 30 Mar 2026 07:00
- Source
- Seeking Alpha
Stock Titan
Direct company coverage
FDA clears Kamada's Texas site to sell plasma worth up to $10M a year
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 26 Mar 2026 07:00
- Source
- Stock Titan
simplywall.st
Direct company coverage
Kamada (TASE:KMDA) Margin Expansion To 11.7% Challenges Cautious Earnings Narratives
- Tone
- Positive 79/100
- Event
- Earnings
- Published
- 11 Mar 2026 07:00
- Source
- simplywall.st
GlobeNewswire
Direct company coverage
Kamada Confirms Continuous Global Business Operations and
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2025 07:00
- Source
- GlobeNewswire
Israel Business News
Direct company coverage
FIMI invests $60m in Kamada for controlling stake - Globes
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 24 May 2023 07:00
- Source
- Israel Business News